Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes

OBJECTIVE: To compare the effect of the rapid-acting insulin analogues (RAIAs) aspart (NovoRapid) and lispro (Prandilin) on glycemic variations by continuous glucose monitoring system (CGMS) in patients within newly diagnosed type 2 diabetes mellitus (T2DM) receiving continuous subcutaneous insulin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Endocrinol
Main Authors: Liu, Bing-li, Yin, Guo-ping, Li, Feng-fei, Hu, Yun, Wu, Jin-dan, Chen, Mao-yuan, Ye, Lei, Su, Xiao-fei, Ma, Jian-hua
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892275/
https://ncbi.nlm.nih.gov/pubmed/29780415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2087960
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados